REG - Marwyn Value Inv Ltd Marwyn Value - MVR2 Marwyn Value - MVIR - Result of Annual General Meeting

Marwyn Value InvestorsAnnouncement

Wed 12:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251210:nRSJ0430La&default-theme=true

RNS Number : 0430L  Marwyn Value Investors Limited  10 December 2025

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE,
PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN
OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA,
JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN
WHICH IT WOULD BE UNLAWFUL TO DO SO

 

 LEI: 213800L5751QTTVEA774

 

10 December 2025

 

MARWYN VALUE INVESTORS LIMITED (THE "COMPANY")

RESULT OF AGM

The Company announces that each of the resolutions which were proposed without
amendment at the Annual General Meeting of the Company held at 10:00 a.m.
today have been passed by the requisite majorities.

Details of the votes cast 'for' and 'against' each resolution, along with any
votes withheld, will be available shortly on the Company's website at
http://www.marwynvalue.com/company-
(http://www.marwynvalue.com/company-information/documents)
information/documents.

Company enquiries:

Marwyn Value Investors Limited
Scott Danks

scottdanks@marwyn.com (mailto:scottdanks@marwyn.com)

 

Company Secretary
Palmer Fund Services (Jersey) Limited

marwyn@palmerfs.com (mailto:marwyn@palmerfs.com)

 

Investor Relations
Kam Bansil
Telephone: 020 7039 1901

 

Corporate Broker - Panmure Liberum Limited
Chris Clarke
Telephone: 0203 100 2200

 

 

Shares in the Company are not designed or intended for retail investors.
Marwyn Investment Management LLP, the Manager, does not promote shares in the
Company to retail investors and they should not be offered to retail
investors.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGPKKBQDBDDABD



            Copyright 2019 Regulatory News Service, all rights reserved